2022 Annual Meeting | C8 - Epilepsy and Neuroimmunology
Program Materials Program Evaluations
07:00 AM - 07:05 AM PDT | Introduction |
Course introduction
Claude Steriade, MD |
07:00 AM - 09:00 AM PDT | Speaker |
walk in slides
Claude Steriade, MD |
07:05 AM - 07:25 AM PDT | Speaker |
Electroclinical Features of Autoimmune Encephalitis and Autoimmune Associated Epilepsy
Lisa Gillinder, FRACP |
07:25 AM - 07:30 AM PDT | Q&A |
Questions and Answers
Lisa Gillinder, FRACP |
07:30 AM - 07:50 AM PDT | Speaker |
Pediatric Aspects of Autoimmune Encephalitis and Autoimmune Associated Epilepsy
Grace Gombolay, MD, FAAN |
07:50 AM - 07:55 AM PDT | Q&A |
Questions and Answers
Grace Gombolay, MD, FAAN |
07:55 AM - 08:15 AM PDT | Speaker |
Seizure Outcomes and Prognostication of Autoimmune Encephalitis
Kelsey M. Smith, MD |
08:15 AM - 08:20 AM PDT | Q&A |
Questions and Answers
Kelsey M. Smith, MD |
08:20 AM - 08:40 AM PDT | Speaker |
Updates on Immunologically-targeted Treatment Approaches in Autoimmune Encephalitis
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
08:40 AM - 08:45 AM PDT | Q&A |
Questions and Answers
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
08:45 AM - 08:50 AM PDT | Speaker |
Case Presentation
Claude Steriade, MD |
08:50 AM - 09:00 AM PDT | Discussion |
Panel Discussion
Claude Steriade, MD, Grace Gombolay, MD, FAAN, Kelsey M. Smith, MD, Sarosh R. Irani, MD, PhD, FRCP, FEAN, Lisa Gillinder, FRACP |
Claude Steriade, MD | The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals. |
Sarosh R. Irani, MD, PhD, FRCP, FEAN | Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB, Immunovant, MedImmun, Roche, Janssen, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics, ADC therapeutics, Brain, CSL Behring, and ONO Pharma.. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
Grace Gombolay, MD, FAAN | Dr. Gombolay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH. |
Kelsey M. Smith, MD | The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals. |
Lisa Gillinder, FRACP | The institution of Dr. Gillinder has received research support from Mater Research Institute. The institution of Dr. Gillinder has received research support from Metro South Health Study, 好色先生 and Research Trust Account (SERTA). The institution of Dr. Gillinder has received research support from Royal Brisbane and Women's Hospital Foundation. The institution of Dr. Gillinder has received research support from Herston Imaging Research Facility Project Support Scheme. The institution of Dr. Gillinder has received research support from Health Innovation, Investment and Research Office (HIIRO). |